View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pertuzumab 840 / Trastuzumab 8 / Letrozole 2.5, Breast Cancer, Neoadjuvant, Cycle 1
Protocol-ID: 2433 V1.1 (Mini), PERT840/TRAS8/LETR2.5, Breast Ca, neoadj., C1Indication(s)
- Breast Cancer (HR+, HER2+); ICD-10 C50.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 09.10.2024